Company news
Arovella Therapeutics Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
SUDA Signs Option To Acquire NovaMist Technology
March 30, 2016
Suda Completes Successful $5.6m Capital Raising
March 30, 2016
Appendix 4D Half Year Ended 31 December 2013
March 30, 2016
Westcoast Expands To East Coast
March 30, 2016
Half Yearly Report and Accounts (including Appendix 4D)
February 26, 2016
SUDA receives $0.7m R&D tax incentive refund
February 11, 2016
Westcoast Surgical & Medical Supplies Update
February 10, 2016
Westcoast Launches Novel Hemostyp Gauze
February 10, 2016
Westcoast Expands Aged Care Activities
February 10, 2016
Update on HC Berlin Pharma AG and Clinical Trials
February 10, 2016
Update On ArTiMist
February 10, 2016
Underwriting of Options
February 10, 2016
SUDA takes full control of ArTiMist
February 10, 2016
Sudas Subsidiary Wins Major Tender
February 10, 2016
Sudas Subsidiary Achieves Record First Quarter Results
February 10, 2016
SUDA sign Sale and Purchase Agreement with Novadel
February 10, 2016
Suda Retains Leading Life Sciences Advisory Firm
February 10, 2016
SUDA receives positive response from FDA regarding SUD-001
February 10, 2016
SUDA progresses business development at BIO 2015
February 10, 2016
Suda Ltd Secures up to $7.6m Project Funding
February 10, 2016
SUDA granted US patent for SUD-002 oral spray
February 10, 2016
Suda Granted First Patent For Sildenafil In Australia
February 10, 2016
SUDA granted African patent for ArTiMist
February 10, 2016
Suda Enters Into Licence Agreement With Amherst
February 10, 2016
Suda completes $5.3m capital raising
February 10, 2016
Suda Completes $1.9m Secured Convertible Note Issue
February 10, 2016
SUDA announces ArTiMist peer-reviewed publications
February 10, 2016
SUDA announces ArTiMist clinical publication
February 10, 2016
SUDA amends agreement with Amherst Pharmaceuticals
February 10, 2016
SUDA allowed first USA patent for SUD-003 and SUD-004
February 10, 2016
Successful placement
February 10, 2016
Shareholder update - July 2011
February 10, 2016
Secures Rights to NiCoSorb
February 10, 2016
Secures key South African Distributor
February 10, 2016
Secures 5.0 Million ClipOn order
February 10, 2016
Rights Issue Shortfall Notice
February 10, 2016
Rights Issue Offer Document
February 10, 2016
Revised Notice of Rights Issue and Timetable
February 10, 2016
Review of PAP Technology
February 10, 2016
Response to Price Query Letter
February 10, 2016
Response to ASX Query re: Share Price
February 10, 2016
Response to ASX Query - Appendix 4C
February 10, 2016
Response to ASX Price and Volume Query
February 10, 2016
Response to ASX Appendix 4D Query
February 10, 2016
Regulatory Approval for Retractable Syringe
February 10, 2016
Prospectus for Non Renounceable Rights Issue
February 10, 2016
Priority Entitlement Offfer and Appendix 3B
February 10, 2016
Portland concludes $5million Supply & Distribution contract
February 10, 2016
Outstanding Results Confirmed in ArTiMist Final Report
February 10, 2016
Outstanding Preliminary results from ArTiMist Phase 3 trial
February 10, 2016
Decks
The 5 newest of 45 decks. Every deck is listed under its year.
- Shareholder Meeting (November 2026)
Shareholder meeting · 45 slides · Nov 4, 2026
- Cell and Gene Meeting on the Mesa 2026
Conference · 18 slides · Oct 6, 2026
- Investor Presentation (August 2026)
Investor deck · 32 slides · Aug 12, 2026
- Investor Presentation (August 2026)
Investor deck · 40 slides · August 2026
- Euroz Hartleys 2026 Healthcare Forum
Conference · 69 slides · Feb 5, 2026